(7-(5-fluoro-2-methoxyphenyl)-2-((2-isopropoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)thieno[3,2-d]pyrimidin-6-yl)methanol manufacturers
|
| | (7-(5-fluoro-2-methoxyphenyl)-2-((2-isopropoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)thieno[3,2-d]pyrimidin-6-yl)methanol Basic information |
| Product Name: | (7-(5-fluoro-2-methoxyphenyl)-2-((2-isopropoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)thieno[3,2-d]pyrimidin-6-yl)methanol | | Synonyms: | (7-(5-fluoro-2-methoxyphenyl)-2-((2-isopropoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)thieno[3,2-d]pyrimidin-6-yl)methanol;EOS-61938;SAR-348830;SAR 348830;SAR348830;SAR-348830;SAR 348830;Thieno[3,2-d]pyrimidine-6-methanol, 7-(5-fluoro-2-methoxyphenyl)-2-[[2-(1-methylethoxy)-4-(4-methyl-1-piperazinyl)phenyl]amino]-;ALK kinase inhibitor-1;kinase,ALK tyrosine kinase receptor,Anaplastic lymphoma kinase,lymphoma,Anaplastic lymphoma kinase (ALK),inhibit,Inhibitor,Cluster of differentiation 246,ALK kinase inhibitor 1,ALK kinase inhibitor-1,ALK kinase inhibitor1,anaplastic,ALK,CD246;7-(5-fluoro-2-methoxyphenyl)-2-{[4-(4-methylpiperazin-1-yl)-2-(propan-2-yloxy)phenyl]amino}thieno[3,2-d]pyrimidin-6-yl]methanol | | CAS: | 1462949-64-9 | | MF: | C28H32FN5O3S | | MW: | 537.65 | | EINECS: | 604-604-1 | | Product Categories: | | | Mol File: | 1462949-64-9.mol | ![(7-(5-fluoro-2-methoxyphenyl)-2-((2-isopropoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)thieno[3,2-d]pyrimidin-6-yl)methanol Structure](CAS/20180703/GIF/1462949-64-9.gif) |
| | (7-(5-fluoro-2-methoxyphenyl)-2-((2-isopropoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)thieno[3,2-d]pyrimidin-6-yl)methanol Chemical Properties |
| Boiling point | 735.9±70.0 °C(Predicted) | | density | 1.300±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO : 100 mg/mL (185.99 mM; Need ultrasonic) | | form | Solid | | pka | 12.88±0.10(Predicted) | | color | Light yellow to yellow |
| | (7-(5-fluoro-2-methoxyphenyl)-2-((2-isopropoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)thieno[3,2-d]pyrimidin-6-yl)methanol Usage And Synthesis |
| Uses | ALK kinase inhibitor-1 is an anaplastic lymphoma kinase (ALK) inhibitor extracted from patent US20130261106A1 compound I-202[1]. | | References | [1] Carry JC, et, al. Novel thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof. US20130261106A1. |
| | (7-(5-fluoro-2-methoxyphenyl)-2-((2-isopropoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)thieno[3,2-d]pyrimidin-6-yl)methanol Preparation Products And Raw materials |
|